These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15615367)

  • 1. [Prevention of cardiovascular diseases: role of the regulatory bodies].
    Addis A
    Ital Heart J; 2004 Nov; 5 Suppl 8():73S-77S; discussion 84S-85S, 116S-121S. PubMed ID: 15615367
    [No Abstract]   [Full Text] [Related]  

  • 2. National Coordinators: an active network dedicated to CVD prevention.
    Squarta S
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S55-7. PubMed ID: 19675439
    [No Abstract]   [Full Text] [Related]  

  • 3. The European Heart Health Charter: towards a healthier Europe.
    Rydén L; Martin J; Volqvartz S
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):355-6. PubMed ID: 17568232
    [No Abstract]   [Full Text] [Related]  

  • 4. The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular disease.
    O'Kelly S; Rydén L
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S58-60. PubMed ID: 19675440
    [No Abstract]   [Full Text] [Related]  

  • 5. [National study program 1: prevention of cardiovascular diseases].
    Soz Praventivmed; 1979 Aug; 24(4):290. PubMed ID: 539163
    [No Abstract]   [Full Text] [Related]  

  • 6. How to improve cardiovascular diseases prevention in Europe?
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):451-4. PubMed ID: 19631516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Internal evaluation of the experience of the National Program of Research 1A on the Prevention of Cardiovascular Diseases. Swiss National Program of Research 1A. Study group].
    Soz Praventivmed; 1981 Sep; 26(4):269-76. PubMed ID: 7303937
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of cardiovascular disease--a possible model for Australian general practice.
    Brett T; McGuire S; Meade B; Leahy J
    Aust Fam Physician; 2006 Mar; 35(3):157-9. PubMed ID: 16525531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care strength linked to prevention programs for cardiovascular disease.
    van Lieshout J; Wensing M; Campbell SM; Grol R
    Am J Manag Care; 2009 Apr; 15(4):255-62. PubMed ID: 19355798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The 2005 BayRad Initiative. Cardiovascular prevention--more necessary than ever].
    Rothe HJ
    Krankenpfl J; 2005; 43(4-6):111. PubMed ID: 16171057
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the Workshop on platelet-active drugs in the secondary prevention of cardiovascular events. February 20-21, 1980, National Institutes of Health, Bethesda, Maryland.
    Circulation; 1980 Dec; 62(6 Pt 2):V1-135. PubMed ID: 7438379
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular nursing in Italy: facing new challenges.
    Laws E; Monasterio FG
    Prog Cardiovasc Nurs; 2009 Jun; 24(2):61-3. PubMed ID: 19523160
    [No Abstract]   [Full Text] [Related]  

  • 14. [Organization of cardiovascular disease control in the USSR].
    Chazov EI
    Ter Arkh; 1980; 52(1):3-9. PubMed ID: 7368117
    [No Abstract]   [Full Text] [Related]  

  • 15. National Research Program 1: data flow and data handling.
    Soz Praventivmed; 1978 Aug; 23(4):282-3. PubMed ID: 706833
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of medical university in modern prevention of cardiovascular diseases. Examples from Medical University of Gdańsk].
    Zdrojewski T; Wierucki L; Ignaszewska-Wyrzykowska A; Zarzeczna-Baran M; Wojdak-Haasa E; Mogilnaya I; Narkiewicz K; Szczech R; Rutkowski M; Bandosz P; Januszko W; Krupa-Wojciechowska B; Wyrzykowski B
    Przegl Lek; 2005; 62 Suppl 3():3-7. PubMed ID: 16521909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The European program for prevention of cardiovascular diseases].
    Heinzl S
    Med Monatsschr Pharm; 2003 Oct; 26(10):335. PubMed ID: 14587152
    [No Abstract]   [Full Text] [Related]  

  • 19. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
    De Backer G; Ambrosioni E; Borch-Johnsen K; Brotons C; Cifkova R; Dallongeville J; Ebrahim S; Faergeman O; Graham I; Mancia G; Manger Cats V; Orth-Gomér K; Perk J; Pyorälä K; Rodicio JL; Sans S; Sansoy V; Sechtem U; Silber S; Thomsene T; Wood D; ; ; ; ; ; ; ;
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1019-30. PubMed ID: 16008181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current topics from legal and social medicine].
    Friederichs H
    Fortschr Med; 1980 Nov; 98(43):1703-4. PubMed ID: 7450651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.